SXTC
China Sxt Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$2.34
−3.90%Margins
Gross margin
17.1%
EBITDA margin
-650.7%
EBIT margin
-664.1%
Net margin
-578.5%
FCF margin
-374.5%
-20.9%
Return on equity
-17.9%
Return on assets
-23.1%
Return on invested capital
0.03x
Asset turnover
-$4.0M
Cash from operations
$21
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026